Published in Lab Invest on October 01, 1984
Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol (1988) 2.93
Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest (1994) 1.63
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest (1995) 1.54
Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. J Clin Invest (1995) 1.24
Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Am J Pathol (2008) 1.08
Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J Exp Med (1999) 1.07
Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3). J Clin Invest (1998) 1.00
Insulin-like growth factor-1 fails to enhance central nervous system myelin repair during autoimmune demyelination. Am J Pathol (2000) 0.88
Amelioration of experimental autoimmune encephalomyelitis in IL-4Ralpha-/- mice implicates compensatory up-regulation of Th2-type cytokines. Am J Pathol (2008) 0.76
Myelination in rat brain: method of myelin isolation. J Neurochem (1973) 4.01
Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med (1999) 3.66
Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol (1988) 3.63
Structural and mechanistic basis of immunity toward endonuclease colicins. Nat Struct Biol (1999) 3.37
Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med (2000) 3.20
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science (1994) 3.00
Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science (1973) 2.91
Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science (1983) 2.91
Observations on viral demyelinating encephalomyelitis. Canine distemper. Lab Invest (1972) 2.88
Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol (1975) 2.86
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol (1991) 2.80
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med (1994) 2.70
Sinusitis of the maxillary antrum. N Engl J Med (1975) 2.57
The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol (1995) 2.57
Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med (1997) 2.51
Late complications of immune deviation therapy in a nonhuman primate. Science (1996) 2.30
Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature (1988) 2.27
Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol (2001) 2.27
The behavioural pattern of social and religious water-contact activities in the Egypt-49 bilharziasis project area. Bull World Health Organ (1966) 2.19
Electron microscopic observations on the cerebellar cortex in kuru. J Neurol Sci (1969) 2.14
Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest (1990) 2.03
Isolation of filaments from brain. Science (1971) 2.03
Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest (1991) 2.01
Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. Proc Natl Acad Sci U S A (1978) 1.97
Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature (1984) 1.95
Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study. Lab Invest (1970) 1.93
GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron (1996) 1.91
Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol (1995) 1.91
Protein-protein interactions in colicin E9 DNase-immunity protein complexes. 1. Diffusion-controlled association and femtomolar binding for the cognate complex. Biochemistry (1995) 1.85
Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol (1991) 1.84
Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest (1984) 1.83
The biology of E colicins: paradigms and paradoxes. Microbiology (1996) 1.81
The cytoskeleton of primary astrocytes in culture contains actin, glial fibrillary acidic protein, and the fibroblast-type filament protein, vimentin. J Neurochem (1981) 1.79
Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol (2001) 1.78
Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol (1995) 1.76
Progress in bilharziasis control. The situation in Egypt. WHO Chron (1967) 1.75
Isolation and characterization of glial filaments from human brain. J Cell Biol (1978) 1.74
An ultrastructural study of experimental demyelination and remyelination. I. Acute experimental allergic encephalomyelitis in the peripheral nervous system. Lab Invest (1969) 1.73
Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol (1991) 1.73
Temperature dependent molecular motion of a tyrosine residue of ferrocytochrome C. FEBS Lett (1976) 1.73
Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol (1990) 1.71
Structural characteristics of protein binding sites for calcium and lanthanide ions. J Biol Inorg Chem (2001) 1.69
The epidemiology of Schistosoma haematobium and S. mansoni infections in the Egypt-49 project area. 4. Measurement of the incidence of bilharziasis. Bull World Health Organ (1966) 1.69
Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis. Proc Natl Acad Sci U S A (1991) 1.65
Specificity in protein-protein interactions: the structural basis for dual recognition in endonuclease colicin-immunity protein complexes. J Mol Biol (2000) 1.64
The lipid composition of purified bovine brain myelin. J Neurochem (1966) 1.62
Myelination in rat brain: changes in myelin composition during brain maturation. J Neurochem (1973) 1.59
Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol (1993) 1.58
On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuroimmunol (1985) 1.56
Axons: isolation from mammalian central nervous system. Science (1972) 1.55
Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53
On the development of CNS lesions in natural canine distemper encephalomyelitis. J Neurol Sci (1976) 1.53
Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion. Cell Immunol (1985) 1.52
Temperature-sensitive mutants of reovirus type 3: defects in viral maturation as studied by immunofluorescence and electron microscopy. Virology (1971) 1.50
Structural parsimony in endonuclease active sites: should the number of homing endonuclease families be redefined? FEBS Lett (1999) 1.45
Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol (1983) 1.45
Chronic experimental allergic encephalomyelitis in inbred guinea pigs. An ultrastructural study. Lab Invest (1974) 1.44
Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int Immunol (1992) 1.43
Hypothesis: a role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis. J Neuroimmunol (1988) 1.42
Ultrastructure of measles virus in cultures of hamster cerebellum. J Virol (1969) 1.42
Invasion of neurones in vitro by non immune lymphocytes. An electron microscopic study. Br J Exp Pathol (1968) 1.41
Progressive demyelination and reparative phenomena in chronic experimental allergic encephalomyelitis. J Neuropathol Exp Neurol (1975) 1.40
The iron oxidation and hydrolysis chemistry of Escherichia coli bacterioferritin. Biochemistry (2000) 1.39
Rapid degradation restricts measles virus matrix protein expression in a subacute sclerosing panencephalitis cell line. Proc Natl Acad Sci U S A (1986) 1.38
Mechanism and cleavage specificity of the H-N-H endonuclease colicin E9. J Mol Biol (2001) 1.36
Reovirus type 3 encephalitis--a virologic and ultrastructural study. J Neuropathol Exp Neurol (1973) 1.36
Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today (1994) 1.35
Isolation of myelin from nerve tissue. Methods Enzymol (1974) 1.35
Isolation and properties of the complex nonheme-iron-containing cytochrome b557 (bacterioferritin) from Pseudomonas aeruginosa. J Inorg Biochem (1987) 1.34
Identification of putative active-site residues in the DNase domain of colicin E9 by random mutagenesis. J Mol Biol (1996) 1.33
Electrostatic interactions in globular proteins: calculation of the pH dependence of the redox potential of cytochrome c551. J Mol Biol (1985) 1.32
Mechanisms of immune injury in multiple sclerosis. Brain Pathol (1996) 1.30
Mucolipidosis IV. Clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy. Arch Neurol (1976) 1.29
Site-directed replacement of the coaxial heme ligands of bacterioferritin generates heme-free variants. J Biol Chem (1995) 1.28
Homing in on the role of transition metals in the HNH motif of colicin endonucleases. J Biol Chem (1999) 1.28
Experimental allergic encephalomyelitis. An electron microscopic study. Am J Pathol (1966) 1.28
Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci (1994) 1.27
Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med (1990) 1.27
The epidemiology of Schistosoma haematobium and S. mansoni infections in the Egypt-49 project area. 2. Prevalence of bilharziasis in relation to personal attributes and habits. Bull World Health Organ (1966) 1.26
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology (1977) 1.26
Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest (1981) 1.25
Subacute sclerosing leukoencephalitis. II. Chemical studies including abnormal myelin and an abnormal ganglioside pattern. J Neuropathol Exp Neurol (1966) 1.24
Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab Invest (1980) 1.24
Tropical spastic paraparesis: a model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neurol (1989) 1.23
Specificity in protein-protein recognition: conserved Im9 residues are the major determinants of stability in the colicin E9 DNase-Im9 complex. Biochemistry (1998) 1.22
Large-scale application of Bayluscide and sodium pentachlorophenate in the Egypt-49 project area. Evaluation of relative efficacy and comparative costs. Bull World Health Organ (1966) 1.22
Quaking mouse: isolation and characterization of myelin protein. J Neurochem (1971) 1.22
Cytochalasin B inhibits the maturation of measles virus. Virology (1983) 1.22
An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system. Lab Invest (1969) 1.20
Glial bridges and Schwann cell migration during chronic demyelination in the C.N.S. J Neurocytol (1978) 1.20